"Exercising at home is unstructured. As great as it is . . . there's nothing more beneficial than being in a gym with a good personal trainer . . . clarifying that what you've read online is what you should (or shouldn't!) be doing . . . I don't buy into the idea that gyms and health clubs are dead," says Dr. Reardon, Founder of FitnessGenes and long time fan of the industry. In this provocative, wide-ranging chat with Pete, they discuss his experience on the front lines battling COVID, the need for an aggressive, new global focus on how people take care of themselves, the dangers of over pathologizing "medical conditions," the importance of building resilience, the dangers of loneliness, vaccines and the critical need to "lose the conspiracies" around them and more!
Dr. Dan Reardon, Co-Founder & CEO, FitnessGenes
Get every new HALO Talks episode!
Each week, host Pete Moore sits down with the founders, operators, finance execs, and investors shaping the Health, Active Lifestyle, and Outdoor sector. Get new episodes in your inbox, no hype or BS, just the people building the sector.
Email has been submitted.
Recent Episodes
- Episode #618: Med Spa Expansion, Regulation, and Niches-Insights from Amanda Guarniere of GuardianMD
- Episode #617: From the Marines to Boardrooms-Jon Sheldon's Lessons on Leadership and Team Dynamics
- HALO Talks Fast Break: Revolutionizing Club Benefits-Amy Bach on Welld Health's Impact Across 10,000 Locations
- Episode #616: Regenerative Medicine, Market Education, and the Future of Wellness-Insights from Bill Quateman
- Episode #615: Inside Austin Pickle Ranch with Tim Klitch-Growth, Community, and Private Equity in Pickleball
- Episode #614: Building Sweathouz (SWTHZ)-Nico Varano on Scaling, Unit Economics, and Operational Excellence
- Episode #613: SoulFire's Formula-Blending Brand Identity, Community, and Profitability in Boutique Fitness
- Episode #612: Building Community Through Contrast Therapy-Carrie Bacon's Vision for 180 Degree Bathhouse
- Episode #611: Outpatient Innovation-Dr. Munir Ghesani Discusses Theranostics, Expansion, and Clinical Trials
- See all →